Reaction
Ocular Vascular Disorder reporting signals
As of the last recalculation, Ocular Vascular Disorder appears in 820 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 37.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 37 | 37.0 | 37.1 |
| Brimonidine Tartrate | 19 | 27.7 | 27.7 |
| Melphalan Hydrochloride | 23 | 23.9 | 23.9 |
| Dorzolamide Hydrochloride And Timolol Maleate | 7 | 22.7 | 22.7 |
| Moxifloxacin Hydrochloride | 17 | 21.7 | 21.7 |
| Latanoprost | 28 | 14.6 | 14.6 |
| Aflibercept | 14 | 11.6 | 11.6 |
| Bimatoprost | 11 | 9.8 | 9.8 |
| Faricimab | 3 | 9.4 | 9.4 |
| Vismodegib | 3 | 8.6 | 8.6 |